Wireless implant monitors heart failure patients at home

NCT ID NCT02729922

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tracked 30 adults with advanced heart failure who received a CardioMEMS implant, a wireless sensor placed in the lung artery to monitor pressure. Patients sent data from home, and doctors used it to guide care. The goal was to see if this approach reduces hospital stays and improves quality of life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

CardioMEMS implantable pulmonary artery sensor

What this could lead to

If successful, this registry could show that CardioMEMS helps reduce heart failure hospitalizations and improve quality of life.

What could go wrong

This is a small, completed registry with only 30 participants, so results may not apply to all heart failure patients. It is observational, not a controlled trial.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART FAILURE, CONGESTIVE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

congestive heart failure heart failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Pennsylvania

    Philadelphia, Pennsylvania, 19104, United States